Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Here comes the selling pressure these license announcements bring.

I've been a shareholder for 13 years and I can tell you I have never seen a stock with as much control or manipulation as this one. With EVERY signing our pps declines, EVERY ONE. Since our short interest is very low, I can only surmise that we are under a naked short attack and have been for many, many months. If someone can come up with a better explanation, I'm all ears. For a time we thought it was Swartz, but after millions upon millions of shares "sold" into any good news I no longer think it is him. What purpose would it serve for him to keep the pps so low. The only entity that could benefit from this type of action IMO is a potential suitor, someone who wants to buy us on the cheap.

This is ridiculous.

Share
New Message
Please login to post a reply